ERNA stock · FTNT stock

ERNA vs FTNT · P/E 0.0, rev $582.0K vs P/E 56, rev $6.80B

Eterna Therapeutics Inc (ERNA) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.

Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.

Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.

Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.

Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.

ERNA currently screens at market cap $6.9M and trailing P/E 0.0. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.

Not investment advice. Open the ERNA and FTNT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons